Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07287332

BLOOM: Pragmatic Feasibility Trial

Led by Mayo Clinic · Updated on 2026-02-06

300

Participants Needed

1

Research Sites

76 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this study is to compare two different ways of dosing cefepime, an antibiotic for very sick patients - the usual approach to dosing or a new dosing method. The new dosing method uses only doses that are available in normal care, but choosing between the different doses is based on more information about the patient's body including their kidney function. The primary purpose of this study is to test how easy it is for healthcare professionals to use the new dosing method and how best to conduct the trial. The study will also assess if the new dosing method helps patients recover faster and reduces side effects.

CONDITIONS

Official Title

BLOOM: Pragmatic Feasibility Trial

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 6518 years of age
  • Admitted to one of the ICUs at the study center
  • Prescribed cefepime therapy by the care team
Not Eligible

You will not qualify if you...

  • Allergy to cephalosporin antibiotics
  • Received more than 1 dose of cefepime in the 24 hours before ICU admission
  • Transferred from an external hospital without compatible electronic health records
  • Missing cystatin C or creatinine lab results needed for dosing
  • Acute kidney injury stage 2 or higher
  • Receiving renal replacement therapy
  • Treated with extracorporeal membrane oxygenation
  • Undergoing molecular adsorbent recirculating therapy at beta-lactam initiation
  • Pregnant
  • Incarcerated
  • Declined Minnesota research authorization

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Mayo Clinic in Rochester

Rochester, Minnesota, United States, 55905

Actively Recruiting

Loading map...

Research Team

G

Gerald W. Flaby Jr., LRT, RRT

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here